| 摘要 |
<p>The present invention relates to pharmaceutical formulations comprising nateglinide that will be used in the treatment of type 2 diabetes (non-insulin dependent) diabetes mellitus where hyperglycaemia cannot be taken under control with diet and exercise.</p> |
